NIZORAL ANTI-DANDRUFF Drug Patent Profile

Which patents cover Nizoral Anti-dandruff, and what generic alternatives are available?

Nizoral Anti-dandruff is a drug marketed by Kramer and is included in one NDA.

The generic ingredient in NIZORAL ANTI-DANDRUFF is ketoconazole. There are fifteen drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nizoral Anti-dandruff

A generic version of NIZORAL ANTI-DANDRUFF was approved as ketoconazole by TARO on June 15^th, 1999.

Summary for NIZORAL ANTI-DANDRUFF

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	47
DailyMed Link:	NIZORAL ANTI-DANDRUFF at DailyMed

Pharmacology for NIZORAL ANTI-DANDRUFF

Drug Class	Azole Antifungal
Mechanism of Action	Cytochrome P450 3A4 Inhibitors Cytochrome P450 3A5 Inhibitors P-Glycoprotein Inhibitors

US Patents and Regulatory Information for NIZORAL ANTI-DANDRUFF

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kramer	NIZORAL ANTI-DANDRUFF	ketoconazole	SHAMPOO;TOPICAL	020310-001	Oct 10, 1997		OTC	Yes	Yes

Expired US Patents for NIZORAL ANTI-DANDRUFF

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Kramer	NIZORAL ANTI-DANDRUFF	ketoconazole	SHAMPOO;TOPICAL	020310-001	Oct 10, 1997
Kramer	NIZORAL ANTI-DANDRUFF	ketoconazole	SHAMPOO;TOPICAL	020310-001	Oct 10, 1997
Kramer	NIZORAL ANTI-DANDRUFF	ketoconazole	SHAMPOO;TOPICAL	020310-001	Oct 10, 1997

EU/EMA Drug Approvals for NIZORAL ANTI-DANDRUFF

Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
HRA Pharma Rare Diseases	Ketoconazole HRA	ketoconazole	EMEA/H/C/003906Ketoconazole HRA is indicated for the treatment of endogenous Cushing’s syndrome in adults and adolescents above the age of 12 years.	Authorised	no	no	yes	2014-11-18

International Patents for NIZORAL ANTI-DANDRUFF

See the table below for patents covering NIZORAL ANTI-DANDRUFF around the world.

Country	Patent Number	Title	Estimated Expiration
U.S.S.R.	786899	METHOD OF PREPARING DERIVATIVES OF 1-(1,3-DIOXOLAN-2-YL-METHYL)-1H-IMIDAZOLES OR -1H-1,2,4-TRIAZOLES OR THEIR ACID-ADDITIVE SALTS IN THE FORM OF MIXTURE OR INDIVIDUAL STEREOISOMERS
Canada	1094559	1-(1,3 DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES ET 1H-1,2,4- TRIAZOLES (1-(1,3-DIOXOLAN-2-YLMETHYL)-1H-IMIDAZOLES AND 1H-1,2, 4-TRIAZOLES)
Hungary	177646	PROCESS FOR PRODUCING NEW 1-BRACKET-1,3-DIOXOLANE-2-YL-METHYL-BRACKET CLOSED-1H-IMIDASOLE DERIVATIVES
Poland	113973
Belgium	896321
South Korea	810000675
Austria	A63678

Market Dynamics and Financial Trajectory for Nizoral Anti-Dandruff

Last updated: July 29, 2025

Overview of Nizoral Anti-Dandruff

Nizoral, a well-established over-the-counter (OTC) and prescription medication, contains the active ingredient ketoconazole. Initially approved for fungal infections, Nizoral’s anti-dandruff formulation has gained dominant market share globally. Its mechanism involves antifungal properties targeting Malassezia furfur, a significant contributor to dandruff and seborrheic dermatitis. Established as a leading brand, Nizoral’s legacy is rooted in efficacy, brand recognition, and broad accessibility.

Market Dynamics

1. Market Size and Growth Drivers

The global anti-dandruff shampoo market was valued at approximately USD 1.8 billion in 2022[1]. It is projected to grow at a compound annual growth rate (CAGR) of around 3.5% over the next five years[2]. The increasing prevalence of dandruff and seborrheic dermatitis, along with heightened consumer awareness for scalp health and haircare, underpin this growth.

2. Competitive Landscape

Nizoral’s main competitors include brands like Head & Shoulders (Procter & Gamble), Selsun Blue (AbbVie/Johnson & Johnson), and ketoconazole-based generics. The market is marked by high brand loyalty, compounded by the over-the-counter accessibility of key products. However, generics and private labels increasingly threaten Nizoral's dominance due to price sensitivity among consumers.

3. Regulatory and Patent Environment

Nizoral’s patent protections in various jurisdictions have historically insulated it from competitors. Yet, patent expirations and the rise of low-cost generics have softened its exclusivity, fostering increased market penetration for competing brands. Regulatory bodies such as the FDA and EMA regularly review safety profiles, impacting formulation modifications and marketing claims.

4. Consumer Trends and Preferences

There is a noticeable shift toward natural, plant-based, and chemical-free alternatives. Consumers also prioritize formulations with added conditioners, scalp soothing agents, and eco-friendly packaging. This trend pressures traditional antifungal shampoos like Nizoral to innovate or diversify their offerings.

5. Impact of COVID-19

The pandemic initially disrupted distribution channels but subsequently increased at-home haircare routines. This amplified demand for OTC haircare products, including anti-dandruff shampoos[3].

Financial Trajectory

1. Revenue Streams

Nizoral's revenue stems from both OTC sales and prescription formulations, with OTC accounting for the bulk of revenue. In key markets such as the US and Europe, Nizoral maintains a strong foothold with an estimated annual sales volume surpassing USD 200 million[4].

2. Pricing Strategies and Margins

Premium positioning and consumer perception of efficacy justify higher price points compared to generics. While this sustains gross margins, intense price competition from generics exerts downward pressure. The average retail price range for Nizoral (8 oz bottle) is USD 10–15, compared to USD 5–8 for generics.

3. Profitability and Cost Structure

Manufacturing costs are relatively stable due to established production processes. Marketing expenses, especially for direct-to-consumer advertising and professional endorsements, constitute significant operating costs. With patent expirations in some key territories, profit margins face potential erosion, but brand loyalty buffers this decline.

4. Market Penetration and Expansion Potential

Emerging markets in Asia-Pacific, Latin America, and Africa present growing opportunities due to increasing awareness and urbanization. Strategic alliances with local distributors and tailoring formulations to regional preferences can propel sales growth.

5. R&D and Innovation Outlook

Investments focus on developing formulations with dual functions—antifungal plus nourishing or natural ingredients. This diversification aims to maintain relevance amid evolving consumer preferences and counter competitive encroachment.

Forecasting the Financial Trajectory

Based on current trends, Nizoral's revenues are expected to experience moderate growth over the next five years. The CAGR of 2.5–3.0% is plausible, factoring in patent expiries, competitive pressures, and market expansion. Cost management, product innovation, and market penetration in underserved regions are critical to sustaining profitability.

---

Key Factors Influencing Future Market and Financial Outcomes

• Patent and Regulatory Landscape: Expiry of patents in major markets will necessitate enhanced focus on generics and biosimilars.
• Consumer Preference Shift: Adoption of natural and multifunctional products requires innovation and marketing adaptation.
• Market Expansion: Strategic entry into emerging markets can offset mature market stagnation.
• Pricing and Competitive Strategies: Balancing premium pricing with affordability amidst rising generic competition.

---

Key Takeaways

• Steady Market Growth: The global anti-dandruff segment is projected to grow modestly but steadily, driven by awareness and lifestyle trends.
• Brand Loyalty and Competition: Nizoral benefits from strong brand recognition but faces increasing competition from generics and natural alternatives.
• Innovation and Diversification: Future success hinges on innovating formulations that align with evolving consumer preferences.
• Emerging Markets as Growth Accelerators: Expanding presence in developing regions can significantly enhance revenue streams.
• Patent Lifecycle Management: Monitoring patent statuses and proactively transitioning to new formulations or markets are vital to safeguarding profitability.

---

FAQs

1. How does Nizoral differentiate itself from rival anti-dandruff shampoos?
Nizoral’s primary differentiator is its active ingredient, ketoconazole, which provides potent antifungal action targeting Malassezia furfur. Its longstanding reputation for efficacy and prescription origin status enhance consumer trust compared to OTC competitors like zinc pyrithione-based shampoos.

2. What impact will patent expirations have on Nizoral’s market share?
Patent expirations generally lead to increased generic competition, reducing Nizoral’s premium pricing power and market share. To mitigate this, the brand can leverage its brand equity, innovate new formulations, and expand into emerging markets.

3. Are natural or plant-based alternatives a threat to Nizoral?
Yes. Consumers shifting toward natural products favor ingredients like tea tree oil, aloe, and botanicals that claim to soothe scalp conditions without chemicals. Nizoral may need to develop or endorse natural formulations to maintain relevance.

4. What are the growth prospects in emerging markets?
Emerging markets present robust growth opportunities due to increasing urbanization, rising disposable incomes, and greater healthcare awareness. Tailored marketing and region-specific formulations can facilitate rapid market penetration.

5. How will ongoing R&D investment influence Nizoral’s future?
Sustained R&D will enable Nizoral to develop dual-function products, incorporate natural ingredients, and improve formulations for better safety and efficacy, thereby strengthening its competitive edge and consumer appeal.

---

Sources

[1] MarketResearch.com, "Global Anti-Dandruff Shampoo Market Report 2022," 2022.
[2] Grand View Research, "Anti-Dandruff Shampoo Market Size & Trends," 2022.
[3] Statista, "Haircare Consumer Trends During COVID-19," 2021.
[4] Company Reports, Johnson & Johnson, 2022.